These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36367230)

  • 21. Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring.
    Liu S; Wang P; Shi X; Weng T; Zhong J; Zhang X; Qu J; Chen L; Xu Q; Meng X; Xiong H; Wu D; Fang D; Peng B; Zhang D
    J Med Virol; 2023 Oct; 95(10):e29125. PubMed ID: 37800607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of SARS-CoV-2-Specific IgA in the Human Milk of COVID-19 Vaccinated Lactating Health Care Workers.
    Valcarce V; Stafford LS; Neu J; Cacho N; Parker L; Mueller M; Burchfield DJ; Li N; Larkin J
    Breastfeed Med; 2021 Dec; 16(12):1004-1009. PubMed ID: 34427487
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine.
    Beharier O; Plitman Mayo R; Raz T; Nahum Sacks K; Schreiber L; Suissa-Cohen Y; Chen R; Gomez-Tolub R; Hadar E; Gabbay-Benziv R; Jaffe Moshkovich Y; Biron-Shental T; Shechter-Maor G; Farladansky-Gershnabel S; Yitzhak Sela H; Benyamini-Raischer H; Sela ND; Goldman-Wohl D; Shulman Z; Many A; Barr H; Yagel S; Neeman M; Kovo M
    J Clin Invest; 2021 Jul; 131(13):. PubMed ID: 34014840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-Severe Acute Respiratory Syndrome Coronavirus 2 IgG Is Present in the Amniotic Fluid of both Infected and Vaccinated Women at Second Trimester of Pregnancy: A Cohort Study.
    La Fauci L; Cavaliere R; Romeo P; Alibrandi A; Ferlazzo G; D'Anna R; Corrado F
    Fetal Diagn Ther; 2023; 50(6):415-421. PubMed ID: 37433286
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies.
    Poon LC; Leung BW; Ma T; Yu FNY; Kong CW; Lo TK; So PL; Leung WC; Shu W; Cheung KW; Moungmaithong S; Wang CC
    Ultrasound Obstet Gynecol; 2021 Jun; 57(6):974-978. PubMed ID: 33798280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of SARS-CoV-2 IgA and IgG in human milk and breastfeeding infant stool 6 months after maternal COVID-19 vaccination.
    Stafford LS; Valcarce V; Henry M; Neu J; Parker L; Mueller M; Vicuna V; Gowen T; Cato E; Kosik I; Yewdell JW; Atkinson M; Cacho N; Li N; Larkin J
    J Perinatol; 2023 Jun; 43(6):775-781. PubMed ID: 36631564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does Maternal SARS-CoV-2 Infection or SARS-CoV-2 Vaccination Trigger an Inflammatory Response in the Fetus? A Prospective Cohort Study.
    Alhousseini A; Turkoglu O; Sajja S; Wharton K; Idler J; Bahado-Singh R
    Gynecol Obstet Invest; 2022; 87(3-4):219-225. PubMed ID: 35728583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of transplacental transfer of mRNA vaccine products and functional antibodies during pregnancy and infancy.
    Prahl M; Golan Y; Cassidy AG; Matsui Y; Li L; Alvarenga B; Chen H; Jigmeddagva U; Lin CY; Gonzalez VJ; Chidboy MA; Warrier L; Buarpung S; Murtha AP; Flaherman VJ; Greene WC; Wu AHB; Lynch KL; Rajan J; Gaw SL
    Nat Commun; 2022 Jul; 13(1):4422. PubMed ID: 35908075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and Neonatal SARS-CoV-2 Immunoglobulin G Antibody Levels at Delivery After Receipt of the BNT162b2 Messenger RNA COVID-19 Vaccine During the Second Trimester of Pregnancy.
    Kugelman N; Nahshon C; Shaked-Mishan P; Cohen N; Sher ML; Gruber M; Marom I; Zolotarevsky A; Lavie O; Damti A; Zilberlicht A; Bardicef M; Kedar R
    JAMA Pediatr; 2022 Mar; 176(3):290-295. PubMed ID: 34932066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting.
    Li Z; Xiang T; Liang B; Deng H; Wang H; Feng X; Quan X; Wang X; Li S; Lu S; Yang X; Wang B; Zelinskyy G; Trilling M; Sutter K; Lu M; Dittmer U; Yang D; Zheng X; Liu J
    Front Immunol; 2021; 12():802858. PubMed ID: 35003131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-vaccination SARS-CoV-2 seroprevalence in children aged 3-11 years and the positivity in unvaccinated children: A retrospective, single-center study.
    Li J; Ge M; Dai S; Song Q; Liu W; Wang Y; Xu W; Ma L
    Front Immunol; 2022; 13():1030238. PubMed ID: 36420275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the immune response using FTIR spectroscopy in mothers and their newborns with different vaccination schemes for COVID-19.
    Mata-Miranda MM; Martinez-Cuazitl A; Gutierrez-Cortes H; Cordero-Hernandez L; Guerrero-Ruiz M; Lopez-Reyes A; Rodriguez-Baez A; Vazquez-Zapien GJ
    Sci Rep; 2024 Jul; 14(1):17308. PubMed ID: 39068230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of the transplacental transmission of SARS CoV-2 virus and antibody transfer according to the gestational age at maternal infection.
    Lucot-Royer L; Nallet C; Vouga M; Puyraveau M; Mauny F; Marty-Quinternet S; Bertholdt C; Bory JP; Devalland C; Canaguier M; Copolla C; Eszto ML; Montoya Y; Roesch M; Reviron S; Riethmuller D; Rufenacht E; Simon E; Mottet N
    Sci Rep; 2024 Feb; 14(1):3458. PubMed ID: 38342940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Maternal Vaccination and Risk of Hospitalization for Covid-19 among Infants.
    Halasa NB; Olson SM; Staat MA; Newhams MM; Price AM; Pannaraj PS; Boom JA; Sahni LC; Chiotos K; Cameron MA; Bline KE; Hobbs CV; Maddux AB; Coates BM; Michelson KN; Heidemann SM; Irby K; Nofziger RA; Mack EH; Smallcomb L; Schwartz SP; Walker TC; Gertz SJ; Schuster JE; Kamidani S; Tarquinio KM; Bhumbra SS; Maamari M; Hume JR; Crandall H; Levy ER; Zinter MS; Bradford TT; Flori HR; Cullimore ML; Kong M; Cvijanovich NZ; Gilboa SM; Polen KN; Campbell AP; Randolph AG; Patel MM;
    N Engl J Med; 2022 Jul; 387(2):109-119. PubMed ID: 35731908
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient Maternofetal Transplacental Transfer of Anti- Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Antibodies After Antenatal SARS-CoV-2 BNT162b2 Messenger RNA Vaccination.
    Rottenstreich A; Zarbiv G; Oiknine-Djian E; Zigron R; Wolf DG; Porat S
    Clin Infect Dis; 2021 Nov; 73(10):1909-1912. PubMed ID: 33822014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dynamic changes of acquired maternal SARS-CoV-2 IgG in infants.
    Wang X; Yang P; Zheng J; Liu P; Wei C; Guo J; Zhang Y; Zhao D
    Sci Rep; 2021 Apr; 11(1):8021. PubMed ID: 33850202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diverging Maternal and Cord Antibody Functions From SARS-CoV-2 Infection and Vaccination in Pregnancy.
    Adhikari EH; Lu P; Kang YJ; McDonald AR; Pruszynski JE; Bates TA; McBride SK; Trank-Greene M; Tafesse FG; Lu LL
    J Infect Dis; 2024 Feb; 229(2):462-472. PubMed ID: 37815524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical impact of maternal COVID-19 on mothers, their infants, and placentas with an analysis of vertical transfer of maternal SARS-CoV-2-specific IgG antibodies.
    Ward JD; Cornaby C; Kato T; Gilmore RC; Bunch D; Miller MB; Boucher RC; Schmitz JL; Askin FA; Scanga LR
    Placenta; 2022 Jun; 123():12-23. PubMed ID: 35512490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcomes of Neonates Born to Mothers With Severe Acute Respiratory Syndrome Coronavirus 2 Infection at a Large Medical Center in New York City.
    Dumitriu D; Emeruwa UN; Hanft E; Liao GV; Ludwig E; Walzer L; Arditi B; Saslaw M; Andrikopoulou M; Scripps T; Baptiste C; Khan A; Breslin N; Rubenstein D; Simpson LL; Kyle MH; Friedman AM; Hirsch DS; Miller RS; Fernández CR; Fuchs KM; Keown MK; Glassman ME; Stephens A; Gupta A; Sultan S; Sibblies C; Whittier S; Abreu W; Akita F; Penn A; D'Alton ME; Orange JS; Goffman D; Saiman L; Stockwell MS; Gyamfi-Bannerman C
    JAMA Pediatr; 2021 Feb; 175(2):157-167. PubMed ID: 33044493
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Humoral Immune Response in Inactivated SARS-CoV-2 Vaccine: When Should a Booster Dose be Administered?].
    Kara E; Tanır F; Demirhindi H; Mete B; Kibar F; Çetiner S; Candevir A; İnaltekin A
    Mikrobiyol Bul; 2022 Jul; 56(3):566-573. PubMed ID: 35960246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.